NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

US STOCKS-Futures plummet as investors dump stocks on fears of pandemic

Published 02/24/2020, 09:08 PM
Updated 02/24/2020, 09:16 PM
US STOCKS-Futures plummet as investors dump stocks on fears of pandemic
DJI
-
GILD
-
NVDA
-
MU
-
AMD
-
VIX
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures drop: Dow 2.59%, S&P 2.47%, Nasdaq 2.77%

By Medha Singh
Feb 24 (Reuters) - U.S. stock index futures tumbled on
Monday as investors scurried to perceived safe-haven assets
after a surge in coronavirus cases outside China stoked fears of
a bigger impact to global economic growth.
Gold rose to a seven-year high and the inversion between the
3-month and 10-year Treasury yields deepened as a rise in cases
in Iran, Italy and South Korea over the weekend added to fears
of a pandemic. An inversion of the curve is a classic recession
sign. US/
Shares of interest rate-sensitive Bank of America Corp
BAC.N , Citigroup Inc C.N , JPMorgan Chase & Co JPM.N ,
Goldman Sachs GS.N , Wells Fargo & Co WFC.N and Morgan
Stanley MS.N lost between 2.1% and 3.7% in premarket trading.
The Dow Jones Industrial Average .DJI was indicated to
open 700 points lower, with all its 30 blue-chip members trading
in the red premarket.
High-growth technology stocks also fell. Apple Inc APPL.O
shed 3.6% as data showed sales of smartphones in China tumbled
by more than a third in January. Chipmakers including Advanced Micro Devices Inc AMD.O ,
Micron Technology Inc MU.O and Nvidia Corp NVDA.O , which are
heavily reliant on China for revenue, slid between 6.3% and
7.2%.]
The CBOE Volatility Index .VIX , a barometer of expected
near-term stock market volatility, jumped to a six-month high.
At 7:40 a.m. ET, Dow e-minis 1YMcv1 were down 752 points,
or 2.59%. S&P 500 e-minis EScv1 were down 82.5 points, or
2.47% and Nasdaq 100 e-minis NQcv1 were down 261.75 points, or
2.77%.
Wall Street's main stock indexes had risen to record highs
last week on optimism that the global economy would be able to
snap back after an initial hit, supported by central banks.
In a bright spot, Gilead Sciences Inc GILD.O , whose
antiviral remdesivir has shown promise in monkeys infected by a
related coronavirus, rose 2.9%.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.